ZFP57-related Transient Neonatal Diabetes Responsive to Oral Sulfonylurea Treatment

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Klin Padiatr 2019; 231(04): 225-226
DOI: 10.1055/a-0889-8307

Short Communication

Ansprechen auf Sulfonylharnstoff bei neonatalem Diabetes durch pathogene ZFP57 Variante

Christina Reinauer

¹Department of General Pediatrics, University Children’s Hospital Duesseldorf, Duesseldorf

,

Carsten Bergmann

²Center for Human Genetics, Bioscientia Ingelheim, Ingelheim

,

Annemarie Jonasson

²Center for Human Genetics, Bioscientia Ingelheim, Ingelheim

,

Volker Soditt

³Department of Pediatrics, Solingen Municipal Hospital, Solingen

,

Ertan Mayatepek

⁴Department of General Pediatrics, University Children’s Hospital Duesseldorf, Duesseldorf

,

Thomas Meißner

¹Department of General Pediatrics, University Children’s Hospital Duesseldorf, Duesseldorf

,

Sebastian Kummer

¹Department of General Pediatrics, University Children’s Hospital Duesseldorf, Duesseldorf

Further Information

Publication Date:
07 May 2019 (online)